Abstract
A total of 215 serum samples were tested for antibodies against human immunodeficiency virus type 2 (HIV-2) with an immunofluorescence assay (IFA). Some samples originated from Denmark and some originated from Guinea-Bissau. The IFA results were compared with enzyme-linked immunosorbent assay (ELISA) and Western (immuno-) blot (WB) results. Twenty-nine serum samples were found to be true positive for HIV-2 antibodies as judged from WB and radioimmunoprecipitation results; all of these were also found to be positive in the HIV-2 IFA. Of 80 serum samples originating from HIV-1-infected persons, 60% showed reactivity in the HIV-2 ELISA, and 51% cross-reacted with at least one band in the HIV-2 WB. None of the sera cross-reacted in the HIV-2 IFA. A total of five serum samples (three African and two Danish) gave unspecific results in the HIV-2 IFA. It is concluded that the HIV-2 IFA is more specific and at least as sensitive as a first-generation ELISA and that IFA is superior to WB in discriminating between HIV-1 and HIV-2 infections.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Blumberg R. S., Sandstrom E. G., Paradis T. J., Neumeyer D. N., Sarngadharan M. G., Hartshorn K. L., Byington R. E., Hirsch M. S., Schooley R. T. Detection of human T-cell lymphotropic virus type III-related antigens and anti-human T-cell lymphotropic virus type III antibodies by anticomplementary immunofluorescence. J Clin Microbiol. 1986 Jun;23(6):1072–1077. doi: 10.1128/jcm.23.6.1072-1077.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Böttiger B., Palme I. B., da Costa J. L., Dias L. F., Biberfeld G. Prevalence of HIV-1 and HIV-2/HTLV-IV infections in Luanda and Cabinda, Angola. J Acquir Immune Defic Syndr. 1988;1(1):8–12. [PubMed] [Google Scholar]
- Carlson J. R., Yee J., Hinrichs S. H., Bryant M. L., Gardner M. B., Pedersen N. C. Comparison of indirect immunofluorescence and Western blot for detection of anti-human immunodeficiency virus antibodies. J Clin Microbiol. 1987 Mar;25(3):494–497. doi: 10.1128/jcm.25.3.494-497.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Clavel F., Mansinho K., Chamaret S., Guetard D., Favier V., Nina J., Santos-Ferreira M. O., Champalimaud J. L., Montagnier L. Human immunodeficiency virus type 2 infection associated with AIDS in West Africa. N Engl J Med. 1987 May 7;316(19):1180–1185. doi: 10.1056/NEJM198705073161903. [DOI] [PubMed] [Google Scholar]
- Cooper D. A., Imrie A. A., Penny R. Antibody response to human immunodeficiency virus after primary infection. J Infect Dis. 1987 Jun;155(6):1113–1118. doi: 10.1093/infdis/155.6.1113. [DOI] [PubMed] [Google Scholar]
- Gallo D., Diggs J. L., Shell G. R., Dailey P. J., Hoffman M. N., Riggs J. L. Comparison of detection of antibody to the acquired immune deficiency syndrome virus by enzyme immunoassay, immunofluorescence, and Western blot methods. J Clin Microbiol. 1986 Jun;23(6):1049–1051. doi: 10.1128/jcm.23.6.1049-1051.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gnann J. W., Jr, McCormick J. B., Mitchell S., Nelson J. A., Oldstone M. B. Synthetic peptide immunoassay distinguishes HIV type 1 and HIV type 2 infections. Science. 1987 Sep 11;237(4820):1346–1349. doi: 10.1126/science.2888192. [DOI] [PubMed] [Google Scholar]
- Horsburgh C. R., Jr, Holmberg S. D. The global distribution of human immunodeficiency virus type 2 (HIV-2) infection. Transfusion. 1988 Mar-Apr;28(2):192–195. doi: 10.1046/j.1537-2995.1988.28288179031.x. [DOI] [PubMed] [Google Scholar]
- Imrie A. A., Kehrer S., Smith G. W., Penny R., Cooper D. A. Seroimmunology of AIDS retrovirus infection. I. Use of immunofluorescence assay to confirm sera with ELISA reactivity. Pathology. 1986 Oct;18(4):438–443. doi: 10.3109/00313028609087565. [DOI] [PubMed] [Google Scholar]
- Lennette E. T., Karpatkin S., Levy J. A. Indirect immunofluorescence assay for antibodies to human immunodeficiency virus. J Clin Microbiol. 1987 Feb;25(2):199–202. doi: 10.1128/jcm.25.2.199-202.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lyons S. F., McGillivray G. M., Coppin A. P., Schoub B. D. Limitations of enzyme immunoassay tests for detection of HTLV-III/LAV antibodies. S Afr Med J. 1985 Oct 12;68(8):575–576. [PubMed] [Google Scholar]
- Nielsen C. M., Kvinesdal B., Vestergaard B. F. Antigen-antibody reaction in solution in capture competition immunoassay for human immunodeficiency virus antibodies. J Clin Microbiol. 1989 Jul;27(7):1609–1612. doi: 10.1128/jcm.27.7.1609-1612.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Norrby E., Biberfeld G., Chiodi F., von Gegerfeldt A., Nauclér A., Parks E., Lerner R. Discrimination between antibodies to HIV and to related retroviruses using site-directed serology. Nature. 1987 Sep 17;329(6136):248–250. doi: 10.1038/329248a0. [DOI] [PubMed] [Google Scholar]
- Sandstrom E. G., Schooley R. T., Ho D. D., Byington R., Sarngadharan M. G., MacLane M. E., Essex M., Gallo R. C., Hirsch M. S. Detection of human anti-HTLV-III antibodies by indirect immunofluorescence using fixed cells. Transfusion. 1985 Jul-Aug;25(4):308–312. doi: 10.1046/j.1537-2995.1985.25485273806.x. [DOI] [PubMed] [Google Scholar]
- Tedder R. S., O'Connor T., Hughes A., N'jie H., Corrah T., Whittle H. Envelope cross-reactivity in Western blot for HIV-1 and HIV-2 may not indicate dual infection. Lancet. 1988 Oct 22;2(8617):927–930. doi: 10.1016/s0140-6736(88)92598-6. [DOI] [PubMed] [Google Scholar]
- Wendler I., Schneider J., Gras B., Fleming A. F., Hunsmann G., Schmitz H. Seroepidemiology of human immunodeficiency virus in Africa. Br Med J (Clin Res Ed) 1986 Sep 27;293(6550):782–785. doi: 10.1136/bmj.293.6550.782. [DOI] [PMC free article] [PubMed] [Google Scholar]
- van der Groen G., Vercauteren G., Piot P. Immunofluorescence tests for HIV antibody and their value as confirmatory tests. J Virol Methods. 1987 Aug;17(1-2):35–43. doi: 10.1016/0166-0934(87)90066-8. [DOI] [PubMed] [Google Scholar]